Search results :

Optison

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Gastrointestinal disorder common x x
Angiopathy common x x
Vomiting uncommon, 4.3% x x x x x x x x
Dizziness postmarketing — 2.5% x x x x x x x x
Headache postmarketing — 2% - 5.4% x x x x x x x x
Renal pain 1.2% x x x
Flushing postmarketing — 1% - 3.6% x x x x x x x x
Nausea uncommon, 1% x x x x x x x x
Back pain uncommon, 0.9% x x x x x x x
Abdominal pain uncommon x x x x
Diarrhoea uncommon x x x x
Dysgeusia uncommon x x x x x
Mediastinal disorder uncommon x x
Injection site pain uncommon x
Throat irritation uncommon x
Sweating increased uncommon x x x x
Blood and lymphatic system disorders uncommon x
Feeling hot uncommon x
Chest pain postmarketing, uncommon x x x x x x x x
Dyspnoea postmarketing, uncommon x x x x x x x x
Fatigue postmarketing, uncommon x x x x x x
Pruritus postmarketing, uncommon x x x x x x x
Anaphylactic shock postmarketing x x x
Angioedema postmarketing x x
Arrhythmia postmarketing x
Arthralgia rare x x x x x x x
Atrial fibrillation postmarketing x x
Bronchospasm postmarketing x x
Transient ischaemic attack postmarketing x
Neck pain rare x
Coma postmarketing x
Cough rare x x x x x x x
Dyspepsia rare x x x x
Oedema postmarketing x
Rash postmarketing, rare x x x x x x x x
Body temperature increased rare x x x x x x x x
Flank pain rare x
Cardiac disorder rare x x x x x
Cardiac failure congestive postmarketing x
Hypersensitivity postmarketing x x x x x x
Hypertension postmarketing, rare x x x x
Hypoaesthesia postmarketing x x
Hypotension postmarketing, uncommon x x x x x x
Cramp muscle rare x
Palpitations rare x x x x x x x
Paraesthesia rare x x x x x x x x
Convulsion postmarketing x x x x x
Shock postmarketing x x
Stridor postmarketing x
Swelling postmarketing x
Syncope postmarketing, rare x x x x
Tachycardia postmarketing, rare x x x x
Supraventricular tachycardia postmarketing x x
Tremor postmarketing x x x x
Loss of consciousness postmarketing x x x x x
Erythema postmarketing, rare x x x x x
Urticaria postmarketing, rare x x x x x x x x
Ventricular fibrillation postmarketing x x
Ventricular tachycardia postmarketing x x x
Wheezing postmarketing x x x x
Ventricular arrhythmia postmarketing x x x x x
Agitation postmarketing x
Acute myocardial infarction postmarketing x
Respiratory arrest postmarketing x x x x x
Rash erythematous rare x x x x
Dry throat rare x
Throat tightness postmarketing x x
Peripheral coldness rare x
Anaphylactoid reaction postmarketing x x x x x
Vision blurred postmarketing x x x x
Rigors rare x x x x
Bradycardia postmarketing, rare x x x x
Respiratory distress postmarketing, rare x x x x x
Electrocardiogram abnormal rare x
Albuminuria x x x
Asthenia x x
Clotting x x x
Conjunctivitis x x x
Connective tissue disorder x
Eosinophilia x x x x x x x
Eye disorder x x
Partial hearing loss x x x
Cardiac arrest x
Haematoma x x x
Haemorrhage x x x
Immune system disorder x x
Cramps of lower extremities x x x
Leukocytosis x x x
Leukopenia x x x
Hypertonia x x x x
Musculoskeletal pain x
Nervous system disorder x x
Pain x x x
Neuropathy peripheral x x x
Pharyngitis x x x
Rhinitis x x x x
Muscle spasms x
Tinnitus x x x x
Tongue disorder x x x x
Toothache x x x
Vertigo x x x
Dry mouth x x x x x x
Chills x x x
Burning sensation x x x
Photophobia x x x
Monocytosis x x
Swelling face x
Ventricular extrasystoles x x x
Injection site reaction x x x
Myocardial ischaemia x
Dry skin x x x
Unspecified disorder of skin and subcutaneous tissue x
Malaise x x
Myalgia x x x x
Urine abnormality x x
Lip swelling x
Eye swelling x
Induration x x x
Influenza-like symptoms x x
Arrhythmia supraventricular x
Lymphadenopathy x x
Face oedema x
Visual disturbance x
Hot flush x x x
Taste altered x x x x
Musculoskeletal discomfort x
Injection site discomfort x x x
Granulocytosis x x x
Airway edema x
Abnormal vision x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

perflutren / perflutren

Side effects:30
Source:EMA

ALBUMIN HUMAN / OPTISON

Side effects:36
Source:FDA

ALBUMIN HUMAN / OPTISON

Side effects:43
Source:FDA

perflutren / perflutren

Side effects:77
Source:EMA

PERFLUTREN / DEFINITY

Side effects:59
Source:FDA

PERFLUTREN / DEFINITY

Side effects:65
Source:FDA

PERFLUTREN

Side effects:85
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label